Public court records · Regulatory sources · Independently maintained Data as of: 2026-09-29 · Not legal advice

Bristol-Myers Squibb

pharma · Ticker: BMY · 1 tracked matter · Last verified:

About the company

The company profile is sourced from neutral references (Wikipedia, official filings) so this page stays a reference, not an opinion. Our own coverage is in the regulatory history and cases below.

Violations & regulatory history

DateRegulatorTypeFine
Jun 26, 2007DOJCriminal fine (off-label promotion)
$619 million criminal fine for off-label promotion of five drugs (per DOJ).
$619,000,000

Cases we track

Products & services involved

  • Xarelto (Rivaroxaban) (manufacturer)

Frequently asked questions

What cases is Bristol-Myers Squibb involved in?

We currently track 1 matter involving Bristol-Myers Squibb: Xarelto (Rivaroxaban) Bleeding. Each links to the full case record with court, status and settlement information.

What has the regulator found about Bristol-Myers Squibb?

Our regulatory history table lists 1 recorded item — actions, settlements and penalties with the regulator, date and amount where published. Every row links to its source.

Where does the Bristol-Myers Squibb information come from?

Company profiles are sourced from neutral references: Wikipedia, official company websites and filings, and regulator records. Our own coverage is the regulatory history table and the case links below.

Affected by Bristol-Myers Squibb products?

Check the case record and start a free review on the relevant case page: Xarelto (Rivaroxaban) Bleeding →